A faculty member in the Division of Rheumatology and Clinical Immunology, Schwartz provides evidence that JAK/STAT-induced bystander activation causes Th9-driven allergic inflammation.
New Nature Immunology paper from Daniella Schwartz, PhD, provides a new potential biomarker to guide precision medicine for IL9-related diseases using JAK inhibitors.
